Protara Therapeutics's three largest insider shareholders as of June 09, 2026 are Management Inc. Opaleye (TenPercentOwner, 1.99Mn shares), Jesse Shefferman (Ceo And President, 1.02Mn shares), Luke M Beshar (Director, 198.00K shares).
| Holder | Position | Shares (Direct) | Shares (Indirect) | Report Date |
|---|---|---|---|---|
| Luke M Beshar | - | 198,000 | 0 | 05 Jul, 2022 |
| Richard S Levy | - | 51,000 | 0 | 19 May, 2025 |
| Management Inc. Opaleye | - | 0 | 1,989,134 | 12 Sep, 2024 |
| Patrick Fabbio | Chief Financial Officer | 64,115 | 0 | 27 Jan, 2026 |
| Jacqueline Zummo | Chief Rd Officer | 94,827 | 0 | 09 Apr, 2026 |
| Jesse Shefferman | Ceo And President | 1,021,832 | 0 | 27 Jan, 2026 |
| Blaine Davis | Chief Financial Officer | 20,662 | 0 | 19 Jul, 2022 |
| William Conkling | Chief Commercial Officer | 76,000 | 0 | 21 Jan, 2026 |
| Jathin Bandari | Chief Medical Officer | 56,704 | 0 | 23 Jan, 2024 |
| Hannah Fry | Vp, Controller | 42,723 | 0 | 27 Jan, 2026 |
| Leonardo Viana Nicacio | Chief Medical Officer | 78,181 | 0 | 21 Jan, 2026 |
* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.
| Transaction Date | Insider Name | Security Class | Transaction Type | Shares Traded | Price | Shares Remaining | Ownership | Code |
|---|---|---|---|---|---|---|---|---|
| 08 Apr, 2026 | Jacqueline Zummo | Common Stock | D | 1,134 | $5.40 | 94,827 | D | S |
| 08 Apr, 2026 | Jacqueline Zummo | Common Stock | D | 1,134 | $5.40 | 94,827 | D | S |
| 01 Apr, 2026 | Jacqueline Zummo | Common Stock | D | 22,598 | $5.26 | 95,961 | D | S |
| 01 Apr, 2026 | Jacqueline Zummo | Common Stock | D | 22,598 | $5.26 | 95,961 | D | S |
| 01 Apr, 2026 | Jacqueline Zummo | Common Stock | D | 22,598 | $5.26 | 95,961 | D | S |
| 26 Jan, 2026 | Jacqueline Zummo | Common Stock | D | 3,724 | $6.67 | 118,559 | D | F |
| 26 Jan, 2026 | Jesse Shefferman | Common Stock | D | 8,732 | $6.67 | 1,021,832 | D | F |
| 26 Jan, 2026 | Jacqueline Zummo | Common Stock | D | 3,724 | $6.67 | 118,559 | D | F |
| 26 Jan, 2026 | Jesse Shefferman | Common Stock | D | 8,732 | $6.67 | 1,021,832 | D | F |
| 26 Jan, 2026 | Patrick Fabbio | Common Stock | D | 3,261 | $6.67 | 64,115 | D | F |
| 26 Jan, 2026 | Jesse Shefferman | Common Stock | D | 8,732 | $6.67 | 1,021,832 | D | F |
| 26 Jan, 2026 | Hannah Fry | Common Stock | D | 1,457 | $6.67 | 42,723 | D | F |
| 26 Jan, 2026 | Jacqueline Zummo | Common Stock | D | 3,724 | $6.67 | 118,559 | D | F |
| 20 Jan, 2026 | Jacqueline Zummo | Common Stock | D | 6,578 | $5.60 | 122,283 | D | F |
| 20 Jan, 2026 | Jesse Shefferman | Common Stock | D | 16,322 | $5.60 | 1,030,564 | D | F |
| 20 Jan, 2026 | Jesse Shefferman | Common Stock | D | 16,322 | $5.60 | 1,030,564 | D | F |
| 20 Jan, 2026 | Patrick Fabbio | Common Stock | D | 3,063 | $5.60 | 67,376 | D | F |
| 20 Jan, 2026 | Jacqueline Zummo | Common Stock | D | 6,578 | $5.60 | 122,283 | D | F |
| 20 Jan, 2026 | Jesse Shefferman | Common Stock | D | 16,322 | $5.60 | 1,030,564 | D | F |
| 20 Jan, 2026 | Jacqueline Zummo | Common Stock | D | 6,578 | $5.60 | 122,283 | D | F |